Transcriptomics in Tumor and Normal Tissues and Precision Oncology Algorithms Identify Early-Stage NSCLC Patients with High Risk of Post-Surgery Recurrence Who May Benefit from Adjuvant Therapies. Lazar, V., Raymond, E., GIRARD, N., Martini, J., Galbraith, S., Raynaud, J., Bresson, C., Solomon, B., Magidi, S., Nechushtan, H., & others bibtex @article{lazartranscriptomics,
title={Transcriptomics in Tumor and Normal Tissues and Precision Oncology Algorithms Identify Early-Stage NSCLC Patients with High Risk of Post-Surgery Recurrence Who May Benefit from Adjuvant Therapies},
author={Lazar, Vladimir and Raymond, Eric and GIRARD, Nicolas and Martini, Jean-Fran{\c{c}}ois and Galbraith, Susan and Raynaud, Jacques and Bresson, Catherine and Solomon, Benjamin and Magidi, Shai and Nechushtan, Hovav and others}
}
Downloads: 0
{"_id":"7Bbpyny6GX9xMRkkE","bibbaseid":"lazar-raymond-girard-martini-galbraith-raynaud-bresson-solomon-etal-transcriptomicsintumorandnormaltissuesandprecisiononcologyalgorithmsidentifyearlystagensclcpatientswithhighriskofpostsurgeryrecurrencewhomaybenefitfromadjuvanttherapies","author_short":["Lazar, V.","Raymond, E.","GIRARD, N.","Martini, J.","Galbraith, S.","Raynaud, J.","Bresson, C.","Solomon, B.","Magidi, S.","Nechushtan, H.","others"],"bibdata":{"bibtype":"article","type":"article","title":"Transcriptomics in Tumor and Normal Tissues and Precision Oncology Algorithms Identify Early-Stage NSCLC Patients with High Risk of Post-Surgery Recurrence Who May Benefit from Adjuvant Therapies","author":[{"propositions":[],"lastnames":["Lazar"],"firstnames":["Vladimir"],"suffixes":[]},{"propositions":[],"lastnames":["Raymond"],"firstnames":["Eric"],"suffixes":[]},{"propositions":[],"lastnames":["GIRARD"],"firstnames":["Nicolas"],"suffixes":[]},{"propositions":[],"lastnames":["Martini"],"firstnames":["Jean-François"],"suffixes":[]},{"propositions":[],"lastnames":["Galbraith"],"firstnames":["Susan"],"suffixes":[]},{"propositions":[],"lastnames":["Raynaud"],"firstnames":["Jacques"],"suffixes":[]},{"propositions":[],"lastnames":["Bresson"],"firstnames":["Catherine"],"suffixes":[]},{"propositions":[],"lastnames":["Solomon"],"firstnames":["Benjamin"],"suffixes":[]},{"propositions":[],"lastnames":["Magidi"],"firstnames":["Shai"],"suffixes":[]},{"propositions":[],"lastnames":["Nechushtan"],"firstnames":["Hovav"],"suffixes":[]},{"firstnames":[],"propositions":[],"lastnames":["others"],"suffixes":[]}],"bibtex":"@article{lazartranscriptomics,\n title={Transcriptomics in Tumor and Normal Tissues and Precision Oncology Algorithms Identify Early-Stage NSCLC Patients with High Risk of Post-Surgery Recurrence Who May Benefit from Adjuvant Therapies},\n author={Lazar, Vladimir and Raymond, Eric and GIRARD, Nicolas and Martini, Jean-Fran{\\c{c}}ois and Galbraith, Susan and Raynaud, Jacques and Bresson, Catherine and Solomon, Benjamin and Magidi, Shai and Nechushtan, Hovav and others}\n}\n\n","author_short":["Lazar, V.","Raymond, E.","GIRARD, N.","Martini, J.","Galbraith, S.","Raynaud, J.","Bresson, C.","Solomon, B.","Magidi, S.","Nechushtan, H.","others"],"key":"lazartranscriptomics","id":"lazartranscriptomics","bibbaseid":"lazar-raymond-girard-martini-galbraith-raynaud-bresson-solomon-etal-transcriptomicsintumorandnormaltissuesandprecisiononcologyalgorithmsidentifyearlystagensclcpatientswithhighriskofpostsurgeryrecurrencewhomaybenefitfromadjuvanttherapies","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/network/files/QpppF92hGWuJ5y5Eh","dataSources":["cDE3DgNwWaCuHMBJA","tZGdDTGBDgYLaWmis","u6vCg6hdprqERxouE","tpPgfZjgEFYmWeP27","B5khaFiqcrF2ex5G6"],"keywords":[],"search_terms":["transcriptomics","tumor","normal","tissues","precision","oncology","algorithms","identify","early","stage","nsclc","patients","high","risk","post","surgery","recurrence","benefit","adjuvant","therapies","lazar","raymond","girard","martini","galbraith","raynaud","bresson","solomon","magidi","nechushtan","others"],"title":"Transcriptomics in Tumor and Normal Tissues and Precision Oncology Algorithms Identify Early-Stage NSCLC Patients with High Risk of Post-Surgery Recurrence Who May Benefit from Adjuvant Therapies","year":null}